Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence.
A phase 3 trial of Anlotinib, Penpulimab in hepatocellular carcinoma, run by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., now recruiting.
Overview
Anlotinib Hydrochloride Capsules Combined With Penpulimab Injection for the Treatment of Hepatocellular Carcinoma at High Risk of Recurrence. is a phase 3 interventional study registered as NCT05862337 by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., with 480 participants planned, started 2023-05-10 and due to reach its primary completion in 2024-08. Interventions recorded: Anlotinib hydrochloride capsules, Penpulimab injection, Anlotinib hydrochloride capsules -matching placebo, Penpulimab injection -matching placebo. Conditions listed: Hepatocellular Carcinoma. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialClinical Trials of Benmelstobart Injection Combined With Anlotinib Hydrochloride Capsules in the Treatment of Advanced or Unresectable Alveolar Soft Part Sarcoma
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialClinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C
Shares Penpulimab, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialClinical Studies for the Treatment of Advanced Solid Tumors
Shares Penpulimab, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialA Clinical Study of TQB2450 Injection Combined With Chemotherapy or Anlotinib Hydrochloride Capsule in the Treatment of Non Small Cell Lung Cancer
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialA Study of Anlotinib Hydrochloride Capsule Combined With Chemotherapy as First-line Treatment in Subjects With RAS/BRAF Wild Metastatic Colorectal Can
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialALTER 0303
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- TrialClinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms
Shares Anlotinib, Sino Biopharmaceutical (Chia Tai Tianqing).
- CollectionCSCO guidelines (China)
Shares Penpulimab, Hepatocellular carcinoma.